Retraction notice to "Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo" [Biochmie 142C (2017) 144-151]

Yunhu Yu; Xiaohong Fu; Qishan Ran; Kaihua Yang; Yuanchao Wen; Hang Li; Fei Wang

doi:10.1016/j.biochi.2022.11.007

Retraction notice to "Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo" [Biochmie 142C (2017) 144-151]

Biochimie. 2023 Jan:204:170. doi: 10.1016/j.biochi.2022.11.007.

Authors

Yunhu Yu¹, Xiaohong Fu², Qishan Ran³, Kaihua Yang², Yuanchao Wen², Hang Li², Fei Wang²

Affiliations

¹ Department of Neurosurgery, The First People's Hospital of Zunyi, Department of Neurosurgery, ZunYi, 563000, China. Electronic address: [email protected].
² Department of Neurosurgery, The First People's Hospital of Zunyi, Department of Neurosurgery, ZunYi, 563000, China.
³ Department of Cerebrovascular Disease, The First Affiliated Hospital of Zunyi Medical College, Zunyi, 563000, China.

PMID: 36623909
DOI: 10.1016/j.biochi.2022.11.007

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Reason for retraction: Figures 5 and 7B show shared images with Figures 4 and 7 of a publication in Mol Med Reports, Zeng et al. (2018) 10.3892/mmr.2018.8599. The two manuscripts were submitted from different laboratories at almost exactly the same time. The authors were contacted but did not respond to the allegation.

Publication types

Retraction Notice